FDA Approved: VELETRI — Original Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA approved VELETRI (epoprostenol) from Actelion as an original application for treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• VELETRI (EPOPROSTENOL)

Snippet

ORIG AP for VELETRI (EPOPROSTENOL)